Microbiological and Antibiotic Profile of Tracheal Aspirate in Mechanically Ventilated Patients in a Tertiary Hospital
DOI:
https://doi.org/10.3126/njms.v10i2.79527Keywords:
Acinetobacter baumannii; Antimicrobial resistance; Tracheal aspirate; Ventilator-associated pneumonia.Abstract
Introduction: Ventilator-associated pneumonia (VAP) is a prevalent hospital-acquired infection in mechanically ventilated patients, leading to increased morbidity, mortality, and antimicrobial resistance. Early identification and understanding of microbiological patterns and antibiotic susceptibility are crucial to optimizing treatment strategies.
Methods:A cross-sectional study was conducted in the ICU of Manipal College of Medical Sciences, Pokhara, from March 5, 2024, to March 6, 2025. Patients on mechanical ventilation for >72 hours exhibiting signs of infection were included. Endotracheal aspirates were obtained and cultured. Pathogens were identified, and antibiotic susceptibility testing was performed. Data were analyzed using SPSS to determine the prevalence, microbiological profile, and antibiotic resistance patterns.
Results: Of 107 patients, 75 (70.1%) had culture-positive tracheal aspirates. The predominant organisms were Gram-negative bacteria (62.5%), notably Acinetobacter baumannii, Klebsiella pneumoniae, and Pseudomonas aeruginosa. A. baumannii showed complete resistance to first-line antibiotics and 92.6% resistance to carbapenems, while all isolates remained sensitive to polymyxin B, colistimethate, and tigecycline. K. pneumoniae demonstrated 60–93.3% resistance to cephalosporins and aminoglycosides. P. aeruginosa was moderately resistant to beta-lactams but susceptible to carbapenems and aminoglycosides. Fungal isolates (Candida spp.) accounted for 4.7%, and Staphylococcus aureus for 2.8%.
Conclusions:This study underscores a high burden of VAP in ICU patients, predominantly caused by multidrug-resistant Gram-negative pathogens. The alarming resistance to first-line antibiotics necessitates robust infection control measures and prudent antibiotic use. Targeted empirical therapy guided by local microbiological trends is vital to improving patient outcomes in mechanically ventilated populations.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Nepal Journal of Medical Sciences

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright © by Nepal Journal of Medical Sciences. The ideas and opinions expressed by authors of articles summarized, quoted, or published in full text in this Journal represents only opinions of authors and do not necessarily reflect the official policy of Nepal Journal of Medical Sciences or the institute with which the author(s) is (are) affiliated, unless so specified.